Dear Friends,

As we reflect on this past year, we have much to be grateful for. With the worst of the COVID-19 pandemic behind us, GO2 reaffirmed our commitment to confronting lung cancer on every front, every day to transform survivorship.

We reached thousands more patients, survivors, caregivers, and those at risk with life-saving and supportive information to help them navigate lung cancer – wherever they were in their journey. Our HelpLine, Living Room series, LungMATCH treatment navigation, PhoneBuddy mentoring program, educational materials, and targeted outreach to our underserved communities offered one-on-one assistance, supportive connections and screening, treatment and survivorship information tailored to each person’s unique needs.

We connected with hundreds more doctors, nurses, navigators and researchers who worked tirelessly with us to provide access to the highest quality screening and treatment in local hospitals – where most people get care. Our Centers of Excellence network defines what excellence means and applies these best practices across the entire care continuum. This includes improving management of incidental pulmonary nodules and increasing access to comprehensive biomarker testing that directs people to the right treatment at the right time.

We expanded our community with record numbers of people joining us and taking action to confront stigma and demand change. Thousands participated in events, elevated their voices and shared their stories. By coming together with one voice we increased national awareness and secured more federal research funding turning hope into reality – locally and globally.

We enlisted more patients and caregivers in our patient driven research initiatives. We recruited for our patient surveys, research studies and other community engagement projects to advance better outcomes for ALL impacted by the disease.

This all folds into transforming survivorship – our overarching mission.

Yes, 2022 set a high bar – but we are committed to raise it even higher in the new year because confronting lung cancer starts here.

Thank you. We look forward to advancing our life-saving work together in the weeks ahead and extend our very best wishes to you and your families in the New Year to come.

Sincerely,

Bonnie J. Addario
Co-Founder and Board Chair

Laurie Fenton Ambrose
Co-Founder, President and CEO